Qube Research & Technologies LTD Biolife Solutions Inc Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$10.54 - $24.2 $159,069 - $365,226	-15,092 Reduced 20.65%	57,976 $801,000
Q1 2022 May 09, 2022	BUY	$20.81 - $37.29 $1.03 Million - $1.85 Million	49,735 Added 213.15%	73,068 $1.66 Million
Q4 2021 Feb 01, 2022	BUY	$32.99 - $58.55 $266,658 - $473,259	8,083 Added 53.0%	23,333 $870,000
Q3 2021 Nov 12, 2021	BUY	$42.03 - $60.5 $640,957 - $922,625	15,250 New	15,250 $645,000
Q2 2021 Aug 13, 2021	SELL	$29.51 - $44.62 $286,896 - $433,795	-9,722 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$32.95 - $44.24 $320,339 - $430,101	9,722 New	9,722 $350,000

199

45M

8.2K

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.16B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.